Cationic Single-Chained Surfactants with a Functional Group at the End of the Hydrophobic Tail DNA Compacting Efficiency

pharmaceutics Article Cationic Single-Chained Surfactants with a Functional Group at the End of the Hydrophobic Tail DNA Compacting Efficiency JoséAntonio Lebrón1, Pilar López-Cornejo 1, Elena García-Dionisio 1, Pablo Huertas 2, Margarita García-Calderón3, María Luisa Moyá1,* , Francisco JoséOstos 1,* and Manuel López-López 4,*   Citation: Lebrón, J.A.; López-Cornejo, P.; García-Dionisio, E.; Huertas, P.; García-Calderón, M.; Moyá, M.L.; Ostos, F.J.; López-López, M. Cationic Single-Chained Surfactants with a Functional Group at the End of the Hydrophobic Tail DNA Compacting Efficiency. Pharmaceutics 2021,13, 589. https://doi.org/10.3390/ pharmaceutics13040589 Academic Editors: Gert Fricker and Ian S. Blagbrough Received: 23 February 2021 Accepted: 15 April 2021 Published: 20 April 2021 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). 1Departamento de Química Física, Facultad de Química, Universidad de Sevilla, C/Profesor García González 1, 41012 Sevilla, Spain; [email protected] (J.A.L.); [email protected] (P.L.-C.); elena_gar[email protected] (E.G.-D.) 2Departamento de Genética, Universidad de Sevilla y Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, 41092 Sevilla, Spain; [email protected] 3Departamento de Bioquímica Vegetal y Biología Molecular, Facultad de Química, Universidad de Sevilla, C/Profesor García González 1, 41012 Sevilla, Spain; [email protected] 4Departamento de Ingeniería Química, Química Física y Ciencias de Materiales, Facultad de Ciencias Experimentales, Universidad de Huelva, Campus de El Carmen, Avenida de las Fuerzas Armadas s/n, 21071 Huelva, Spain *Correspondence: [email protected] (M.L.M.); [email protected] (F.J.O.); [email protected] (M.L.-L.); Tel.: +34-954557175 (M.L.M.) Abstract: The interaction between calf-thymus DNA, ctDNA, and various single-chained surfactants with different functional groups at the end of hydrophobic tail was studied with the goal of investigating the influence of the functional group nature on surfactant DNA compacting efficiency. The surfactants investigated were dodecyltriethylammonium bromide (DTEABr), triethyl(1phenoxydodecyl)ammonium bromide (12PhBr), triethyl(2-naphthoxydodecyl)ammonium bromide (12NBr) and 11-(isonicotinoyloxy)-N,N,N-triethyl-1-undecanaminium bromide (11PyBr). Results made evident that the surfactants’ tendencies to self-aggregation is the key factor determining their efficiency to compact the nucleic acid. Subsequently, DOPE/12NBr/pEGFP-C1 lipoplexes, with different cationic surfactant molar fractions ( α ) and mass ratios (L/D), were prepared and characterized. DOPE is a zwitterionic phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, and the plasmid pEGFP-C1 carries a GFP coding sequence with the necessary regulatory elements for constitutive expression of the gene in human cells. 12NBr was chosen because it was the most efficient DNA compacting agent among the surfactants investigated. Finally, the cytotoxicity and transfection efficiency (TE) of DOPE/12NBr/pDNA lipoplexes, with different compositions, were investigated. Keywords: cationic surfactants; DNA compacting efficiency; liposomes; lipoplexes; gene transfection 1. Introduction Research on the interactions between surfactants and nucleic acids has drawn great attention in the last decades for its significance in biomedical and biotechnological applications, particularly for the possibility of using surfactant/DNA systems for gene delivery [ 1 – 7 ]. Since it is difficult for DNA to cross negatively charged cell membranes due to its high negative charge and bulky size, the surfactant gene vectors should compact DNA molecules into small particles, protecting them from the degradation of nucleases. Subsequently, they penetrate through the membrane into the cells, where the surfactant/DNA complexes decompact to release the genetic charge [ 2 , 8 ]. On these bases, the study of the conformational changes of DNA induced by the interaction with surfactants is of great significance in developing practical technologies for biomedical engineering. Many methods have been used in the investigation of DNA compaction by surfactants, both involving a large number of molecules [9–13] and at a singular molecule level [14–18]. Pharmaceutics 2021,13, 589. https://doi.org/10.3390/pharmaceutics13040589 https://www.mdpi.com/journal/pharmaceutics Pharmaceutics 2021,13, 589 2 of 23 The characteristics of the surfactants strongly determine the surfactant/DNA interactions. Anionic, nonionic and cationic surfactants have been investigated and, due to the charge complementarity, cationic surfactants have been shown to be by far the most efficient DNA compacting agents, inducing a morphological transition of the nucleic acid from an elongated form to a globular form [ 1 , 3 – 5 , 7 , 12 , 13 , 19 – 24 ]. An increment in the positive charge of the surfactant head group, or in the number of the positively charged head groups, tends, a priori, to increase the surfactant DNA compacting efficiency due to an increment in the electrostatic attractions between the negatively charged DNA and the surfactant [ 25 , 26 ]. The influence of the counter ion nature, the effect of substituting H atoms by F atoms in the hydrophobic chains, and the impact of the magnetic properties of the surfactants on the surfactant/DNA interactions, have also been investigated [27–29]. The importance of hydrophobic interactions has been demonstrated, in addition to electrostatic effects, in the DNA-condensing capacity of surfactants. An increase in hydrophobic chain length and the presence of additional side hydrophobic tails, results in an improved compacting efficiency [16,30,31]. More favorable hydrophobic interactions also explain that, for a given tail length, dimeric surfactants are more efficient DNA-condensing agents than single-chained surfactants [ 1 , 4 , 5 , 25 – 28 , 32 – 36 ]. Spacer length, which is a structural characteristic specific for oligomeric surfactants, also influences the surfactant/DNA interactions [ 37 – 41 ]. Recently, the effects of the degree of oligomerizarion of surfactants, as well as of the structure of the spacer group linking the individual surfactant fragments, have been examined [ 42 ]. The conclusion was that the DNA compacting efficiency of these surfactants is not simply connected to their degree of oligomerization, but is the result of a complex balance of the number and relative distances of the positively charged head groups and/or hydrophobic chains in the surfactant, which makes the interaction with the nucleic acid more effective, rendering appropriate surfactant/DNA complexes. Even though surfactant/DNA interactions have been studied in numerous papers, to the authors’ knowledge, the influence of the incorporation of a functional group at the end of the hydrophobic surfactant tail on the surfactant DNA compacting capacity has not been investigated. With this goal, the interactions between calf-thymus DNA, ctDNA, and the cationic surfactants 11-(isonicotinoyloxy)-N,N,N-triethyl-1-undecanaminium bromide (11PyBr), dodecyltriethylammonium bromide (DTEABr), triethyl(1-phenoxydodecyl)ammonium bromide (12PhBr), and triethyl(2-naphthoxydodecyl)ammonium bromide (12NBr) (see Scheme 1) were studied. The hydrophobicity of DTEABr, 12PhBr, and 12NBr increases following the trend DTEABr < 12PhBr < 12NBr because of the introduction of the phenoxy and naphthoxy groups at the end of the hydrophobic tail (the three surfactants have a 12-carbon chain). As a consequence, the expected trend in the cmc is cmc(DTEABr) > cmc(12PhBr) > cmc(12NBr). This would permit investigation of the influence of the surfactant tendency to self-aggregate on its DNA compacting capacity for surfactants with functional groups at the end of the hydrophobic tail. On the other hand, 11PyBr has an aromatic functional group at the end of the tail, but an 11-carbon chain. Therefore, information about the influence of the tail length on the surfactant/DNA interactions could be obtained. Subsequently, liposomes of different compositions containing DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) and the surfactant with the highest DNA compacting efficiency, 12NBr, were prepared. The formation and characterization of several DOPE/12NBr/pDNA lipoplexes, where pDNA is the plasmid pEGFP-C1, were done. Cytotoxicity of these lipoplexes in a human bone osteosarcoma epithelial U2OS cell line was studied, and then the transfection efficiency (TE) of these DOPE/12NBr/pDNA lipoplexes in the same cell line was investigated. These studies are relevant considering that, after a better understanding of the DNA compaction process by the surfactants studied, the search for more effective cationic surfactant nonviral vectors for gene therapy would be a priority research goal, given the number of rare disorders in the population which need medical solutions. Pharmaceutics 2021,13, 589 3 of 23 Pharmaceutics 2021, 13, x 3 of 23 was studied, and then the transfection efficiency (TE) of these DOPE/12NBr/pDNA lipoplexes in the same cell line was investigated. These studies are relevant considering that, after a better understanding of the DNA compaction process by the surfactants studied, the search for more effective cationic surfactant nonviral vectors for gene therapy would be a priority research goal, given the number of rare disorders in the population which need medical solutions. Scheme 1. Structure of the surfactants investigated in this work. 2. Materials and Methods 2.1. Materials Red Safe was purchased from iNtRON (Biotechnologiy, Chicago, IL, USA). The lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) was obtained from Avanti Polar Lipids (Alabaster, AL, USA). The rest of the reagents were from Sigma Aldrich (Darmstadt, Germany) of the highest purity available, and used as received. The pEGFP-C1 plasmid (Clontech, Biocientífica S.A., Buenos Aires, Argentina), pDNA, was extracted from competent E. coli bacteria previously transformed with pEGFP-C1. The extraction was done using a GenElute HP Select Plasmid Gigaprep kit (Sigma Aldrich, Darmstadt, Germany) following a protocol previously described [43]. FuGENE 6 was from Promega Corporation (Madison, WI, USA). ctDNA concentration was estimated using absorbance measurements at 260 nm (molar absorptivity 6600 mol −1 dm 3 cm −1 [44]). An agarose gel electrophoresis test using ethidium bromide (EB) indicated that the average number of base pairs was above 10,000 bp [45]. The ctDNA concentration was expressed per base-pairs. The syntheses of the cationic surfactants were previously described [46–48]. Their purity (≥99%) was checked by 1 H and 13 C NMR, elemental analysis and mass spectra. MilliQ water (resistivity > 18 MΩ·cm) was used to prepare all solutions. The pH was maintained constant at 7.4 by using 10 mM HEPES (4-(2-hydroxyethyl)piperazine-1ethanesulfonic acid sodium salt) buffer. All measurements were done at 303.0 ± 0.1 K. 2.2. Preparation of Surfactant/ctDNA Solutions Surfactant/ctDNA solutions were prepared by using the following method. A stock ctDNA solution (∼5 × 10 −4 M) was prepared in buffer HEPES 10 mM, at pH = 7.4 and several aliquots were stored at −70 °C. The required amounts of the different surfactants were weighed in order to prepare stock surfactant solutions in HEPES 10 mM (pH = 7.4). Scheme 1. Structure of the surfactants investigated in this work. 2. Materials and Methods 2.1. Materials Red Safe was purchased from iNtRON (Biotechnologiy, Chicago, IL, USA). The lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) was obtained from Avanti Polar Lipids (Alabaster, AL, USA). The rest of the reagents were from Sigma Aldrich (Darmstadt, Germany) of the highest purity available, and used as received. The pEGFP-C1 plasmid (Clontech, Biocientífica S.A., Buenos Aires, Argentina), pDNA, was extracted from competent E. coli bacteria previously transformed with pEGFP-C1. The extraction was done using a GenElute HP Select Plasmid Gigaprep kit (Sigma Aldrich, Darmstadt, Germany) following a protocol previously described [ 43 ]. FuGENE 6 was from Promega Corporation (Madison, WI, USA). ctDNA concentration was estimated using absorbance measurements at 260 nm (molar absorptivity 6600 mol −1 dm 3 cm −1 [ 44 ]). An agarose gel electrophoresis test using ethidium bromide (EB) indicated that the average number of base pairs was above 10,000 bp [ 45 ]. The ctDNA concentration was expressed per base-pairs. The syntheses of the cationic surfactants were previously described [ 46 – 48 ]. Their purity (≥99%) was checked by 1H and 13C NMR, elemental analysis and mass spectra. MilliQ water (resistivity > 18 M Ω· cm) was used to prepare all solutions. The pH was maintained constant at 7.4 by using 10 mM HEPES (4-(2-hydroxyethyl)piperazine-1ethanesulfonic acid sodium salt) buffer. All measurements were done at 303.0 ±0.1 K. 2.2. Preparation of Surfactant/ctDNA Solutions Surfactant/ctDNA solutions were prepared by using the following method. A stock ctDNA solution (~5 × 10 −4 M) was prepared in buffer HEPES 10 mM, at pH = 7.4 and several aliquots were stored at − 70 ◦ C. The required amounts of the different surfactants were weighed in order to prepare stock surfactant solutions in HEPES 10 mM (pH = 7.4). Cationic surfactant/ctDNA solutions, with 3.0 × 10 −5 M of ctDNA, at the desired charge ratio cationic surfactant/ctDNA (N/P) were prepared adding the required volumes of the stock solutions and using the buffer as solvent. All solutions were freshly prepared before use. In the case of the AFM experiments, solutions were prepared using the same method, but the ctDNA concentration was different (see Section 2.9). 2.3. Preparation of Lipoplexes The lipid thin-film hydration method was used to prepare the liposomes [ 49 ]. Concisely, adequate quantities of surfactants and DOPE were dissolved in chloroform. Different Pharmaceutics 2021,13, 589 4 of 23 volumes of these solutions were mixed in order to obtain the desired cationic lipid molar fraction, α, given by Equation (1): α=nsurfactant nsurfactant +nDOPE (1) where n surfactant and n DOPE are the mole number of the cationic surfactant and the zwitterionic DOPE, respectively, in the total volume of the organic solution. The organic solvent was evaporated by using a rotary evaporator at 303 K for 50 min, obtaining a dry lipid film which was stored for at least 24 h at 193 K to avoid degradation [ 50 ]. Subsequently, the lipid film was hydrated with 2 mL of an aqueous buffered solution (HEPES 10 mM, pH = 7.4) and submitted to 10 cycles of vortex (3 min/1200 rpm) and sonic action (2 min, JP Selecta Ultrasons system 200 W, 50 kHz, Abrera, Barcelona, Spain). Finally, the solution was vortexed at room temperature for 2 h. The resulting liposomes were multilamellar, with a high polydispersity. In order to obtain unilamellar liposomes with a homogeneous size distribution, the liposome solutions were extruded 10 times with a mini extruder from Avanti Polar Lipids (Birmingham, AL, USA), using polycarbonate membranes of 100 and 200 nm (Whatman, Maidstone, UK). After extrusion, the solutions were kept in the dark at 277 K for 24 h to obtain complete stabilization. The lipoplexes were prepared by mixing appropriate volumes of both liposome and aqueous HEPES 10 mM pDNA solutions in order to obtain the desired L/D values for each α value investigated. No dilution was used. The mass ratio L/D is defined by Equation (2): L D=msurfactant +mDOPE msurfactant (2) here m DOPE , m surfactant , and m DNA are the masses of the zwitterionic phospholipid of the surfactant, and of the DNA, respectively, in the solution. In all the liposome solutions investigated, the mass of DNA was kept constant at 10 −4 g (8.1 × 10 −5 M given in base-pairs). The stability of the DOPE/12NBr/pDNA lipoplexes was followed by changes in their size with time. The size remained unchanged for more than 48 h. The authors also checked the stability of DOPE/12NBr/pDNA lipoplexes of different compositions after dilution with buffer HEPES 10 mM. No variations in their size were observed. 2.4. UV-Visible Spectroscopy UV-visible spectroscopy was used to check the stability of the surfactant/ctDNA solutions. A spectrophotometer Hitachi UV-visible 3900 (Chiyoda, Tokyo, Japan) was used. It was connected to a water flow Lauda cryostat (Stuttgart, Baden-Würtenberg, Germany) for controlling temperature, which was kept at 303.0 ± 0.1 K. No changes in absorbance were observed at 260 nm for more than 48 h in all systems investigated. Nonetheless, the surfactant/ctDNA solutions were freshly prepared before used. 2.5. Fluorescence Measurements A Hitachi F-2500 spectrofluorimeter (Chiyoda, Tokyo, Japan) interfaced to a PC for the recording and handling of the spectra, and connected to a flow Lauda thermostat (Stuttgart, Baden-Würtenberg, Germany) to maintain the temperature at 303.0 ± 0.1 K, was used with a standard fluorescence quartz cell of 10 mm path length. Ethidium bromide (EB) emission fluorescence intensity was measured using excitation and emission wavelengths of 520 and 588 nm, respectively. EB emission spectra were recorded from 530 to 700 nm with a scan rate of 60 nm/min and excitation and emission slits equal to 5 nm for both. The EB and ctDNA concentrations were kept constant at 4.9 ×10−6M and 3.0 × 10 −5 M, respectively, while changing the surfactant concentration. All the solutions studied were buffered (HEPES 10 mM, pH = 7.4). Data are expressed as mean±SD from at least three separate experiments, n= 3. Pharmaceutics 2021,13, 589 5 of 23 2.6. Zeta Potential Measurements Zeta-potential, ζ , values were calculated measuring the electrophoretic mobility of both the surfactant/DNA and the DOPE/12NBr/pDNA solutions from the velocity of the particles using a laser Doppler velocimeter (LDV). The experiments were done with a Zetasizer Nano ZS Malvern Instrument Ltd. (Malvern, Worcestershire, UK) at 303.0 ±0.1 K . DTS1060 polycarbonate capillary cells were used. DNA concentrations used were 3.0 ×10−5M in the surfactant/DNA buffered solutions and 8.1 × 10 −5 M in the buffered solutions of liposomes. Data are expressed as mean ± SD from at least three separate experiments, n= 9. 2.7. Dynamic Light Scattering (DLS) Measurements A Zetasizer Nano ZS Malvern Instrument Ltd. (Worcestershire, UK) was used to estimate the size and the polydispersity index (PDI) of the DOPE/12NBr/pDNA lipoplexes using DLS measurements. A scattering angle of 90 ◦ with a helium-neon laser was utilized, and the apparatus analyzed the fluctuations in the intensities of the scattered light. A fixed concentration of 8.1 × 10 −5 M of the plasmid pDNA was present in all the solutions investigated. Composition of the lipoplex solutions was changed, keeping constant different α values and varying the L/D ratio. Data are expressed as mean ± SD from at least three separate experiments, n= 10. Temperature was maintained at 303.0 ±0.1 K. 2.8. Agarose Gel Electrophoresis Agarose gel (1%) was prepared in a TAE buffer (1 mM EDTA, 40 mM Tris-acetate) in a total volume of 180 µ L and stained with the dye Red-Safe (10 µ L) for the visualization of the nucleic acid bands. The ctDNA concentration was kept constant at 3 × 10 −5 M for the surfactant/ctDNA solutions while changing the surfactant concentration. In the case of the DOPE/12NBr/pDNA lipoplex solutions, the pDNA concentration was 8.1 × 10 −5 M. Composition of the lipoplex solutions was changed by keeping constant the different α values and varying the L/D ratio. In each experiment, 20 µ L of the DOPE/12NBr liposome solution were mixed with 5 µ L of 5 × DNA loading buffer. Then, after homogenization, the resulting solutions were added in each well. Electrophoresis was carried out for 90 min at 90 V. A detector Ultima 16si (Hoefer, Germany) was used for visualizing the nucleic acid bands by irradiation with UV light (254 nm). 2.9. Circular Dichroism Spectra The circular dichroism (CD) spectra were recorded in a Biologic Mos-450 spectropolarimeter (Cambridge, UK). A standard quartz cell of 10 mm path length was utilized, and scans were taken from 220 to 310 nm. Three independent experiments were carried out and each spectrum was obtained from an average of 10 runs at a fixed temperature of 303.0 ± 0.1 K, with a 5 min equilibration before each scan. The ctDNA concentration was kept constant at 3.0 × 10 −5 M, for the surfactant/ctDNA solutions while changing the surfactant concentration. The pDNA concentration remained constant at 8.1 × 10 −5 M in the lipoplex solutions. For a given α value, the ratio L/D was changed. All solutions were prepared in 10 mM HEPES buffer at pH 7.4. 2.10. Atomic Force Microscopy, AFM The structures of the surfactant/ctDNA complexes were investigated using AFM. A Molecular Imaging PicoPlus 2500 AFM (Agilent Technologies, Santa Clara, CA, USA) was used. A resonance frequency of around 240 KHz and a nominal force constant of 42 N/m were the working conditions, using silicon cantilevers (Model Pointprobe, Nanoworld, Neufchâtel, Switzerland). The images were recorded in air and in tapping mode. Data collection was registered at 256 × 256 pixels, with scan speeds about 0.5 Hz. The ctDNA concentration was 0.6 µM, keeping pH = 7.4 (HEPES 10 mM). Images of surfactant/ctDNA buffered solutions were obtained using the following method. (i) 0.1% (v/v) APTES aqueous solution was dropped onto a freshly cleaved mica Pharmaceutics 2021,13, 589 6 of 23 surface in order to prepare a modified mica surface. After 20 min, it was washed with ultrapure water and air dried. (ii) A 30 µ L droplet of the surfactant/ctDNA buffered solution was deposited on the modified mica surface and incubated for 30 min. (iii) Afterwards, it was washed with pure water and air dried for AFM imaging. 2.11. Electron Transmission Microscopy (TEM) A Zeiss Libra 120 scanning electron microscope at 80 kV was used to characterize the DOPE/12NBr liposomes and the DOPE/12NBr/pDNA lipoplexes. A 300-mesh copper grid coated with collodion was impregnated with the samples and, subsequently, it was stained with a solution of uranyl acetate (2.0%). Images were processed with a bottom mounted TEM CCD camera and recorded with a resolution of 2048 × 2048 pixels. The pDNA concentration in the lipoplexes formed was 2.5 ×10−5g/mL. About 100 particles were taken into account from different images obtained for independent experiments corresponding to each studied system. ImageJ bundled with 64-bit Java 1.8.0_172 was used to analyze TEM images. 2.12. In Vitro Cytotoxicity Assays The cytotoxicity of the lipoplexes with α 0.2, 0.3, and 0.7, at different L/D values, was estimated in vitro by using the MTT assay [ 51 ]. Cell lines were plated out into 96 well plates at a density of 7000 cells per plate. The U2OS cell line was used in order to evaluate the cytotoxicity of these lipoplexes. The next day, different doses of lipoplex solutions were added to the wells, keeping the pDNA amount constant at m pDNA = 2 µ g, and the plate returned to the incubator for two days more. Later, they were pulsed with MTT (ROCHE, Basilea, Switzerland). Cell viability was measured by luminometry according to the manufacturer instructions in Varioskan Flash (Thermo Electron Corporation) and normalized with control (FuGENE ® HD, Promega, E2311). Each L/D value investigated was measured in triplicate. The cell line used is from ATTC ® HTB-96 TM (ATCC, Manassas, VA, USA). 2.13. Transfection Assays The plasmid pEGFP-C1, pDNA. was used for these experiments given that it carries an enhanced GFP coding sequence with the required regulatory elements for constitutive expression of the gene in human cells. The cell line chosen was the U2OS from human osteosarcoma because it is an easy-to-transfect cell line. For this reason, it has been frequently used in human molecular and cellular biology studies. The pDNA nonviral vectors used were DOPE/12NBr liposomes of different compositions. The following method was used to carry out the transfection experiments: 3 µ g of pDNA was added to a solution containing 180 µ L of Opti-MEM (Gibco) and the amount of liposome buffered solution (HEPES 10 mM) necessary to obtain the L/D ratio for each α value investigated. The resulting mixture was incubated at room temperature for 20 min and, subsequently, added to a 50% confluent 6 cm plate with 3 mL of DMEM medium. As negative control, the cells were transfected only with a mixture of transfection reagent and Opti-MEM (not plasmid DNA included). As a positive control we used FuGENE ® HD transfection reagent (Promega, E2311) according to the manufacturer’s protocol (i.e., 3 µ g of plasmid DNA in 200 µ L Opti-MEM plus 9 µ L of FuGENE ® HD). Transfection efficiency was evaluated by flow cytometry with a FACSCalibur (BD) 24 h after transfection. 2.14. Statistical Analysis Values are expressed as the mean ± standard errors of separate experiments. Statistical analysis was performed with Student’s t-test and One-way analysis of variance (ANOVA). When p< 0.05 (95% confidence) the differences were considered as significant. Pharmaceutics 2021,13, 589 7 of 23 3. Results and Discussion 3.1. DNA Compacting Efficiency of the Surfactants The surfactant concentration present in the solutions was always lower than the cmc in order to avoid the aggregation of the amphiphilic molecules. Table S1 (Supplementary Material) summarizes the cmc of the surfactants investigated in this work at 303 K, taken from [46–48] . The tendency to self-association follows the trend 12NBr > 12PhBr >> DTEABr. The cmc corresponding to 11PyBr is not listed in this table because this surfactant does not aggregate in aqueous solutions. The stability of the surfactants/ctDNA solutions was checked by registering the UV-visible spectra with time. In all cases neither absorbance changes at 260 nm nor turbidity were observed for at least 48 h. There are several methods for investigating the DNA compacting capacity of surfactants and other species. One of the easier and more frequently used is the ethidium bromide (EB) competitive assay [ 52 – 54 ]. EB is a planar dye that intercalates between adjacent base pairs of double stranded DNA, resulting in an enhancement of its fluorescence emission intensity. Changes in this magnitude when a surfactant is added to an EB/ctDNA solution can provide information about surfactant/ctDNA interactions. Figure 1a shows the dependence of I/Io on the N/P ratio. N/P = (1 × M surfactant )/(k × M DNA ), where M surfactant and M DNA are molar concentrations of the surfactant and of the nucleic acid (expressed in base pairs), respectively, 1 is the charge of the surfactants investigated and k represents the quantity of negative charge attributable to the nucleic acid molecules per base pair, which is equal to 2 [ 55 ]. Io and I are the fluorescence emission intensities of EB in the absence and in the presence of surfactant, respectively. One can see in this figure that 12NBr and 12PhBr practically displaced all EB molecules from their intercalation site in ctDNA to the bulk solution. DTEABr and, particularly, 11PyBr only partially displaced the dye. Nonetheless, these results indicate that all the cationic surfactants studied interacted with the nucleic acid, the trend observed being 12NBr > 12PhBr >> DTEABr > 11PyBr. The displacement of the dye molecules to the bulk could be due to conformational changes caused by the surfactant/ctDNA interactions. Conformational changes in nucleic acids are usually accompanied by a charge inversion. In order to investigate this point, zeta potential measurements, ζ were carried out in buffered surfactant/ctDNA solutions, keeping constant the nucleic acid concentration while varying the surfactant concentration. Figure 1b shows the dependence of ζ on the charge ratio N/P for the surfactants investigated. One can see in this Figure that 12NBr and 12PhBr caused a charge inversion of the nucleic acid, reaching a high positive charge. DTEABr/ctDNA complexes reached a low positive charge at high surfactant concentration, whereas 11PyBr was not able to provoke the charge inversion even at really high 11PyBr concentrations.These results point out the large differences in the interactions of the surfactants investigated with ctDNA. The charge inversion has previously been associated with the condensation and conformational changes of the nucleic acid in the surfactant/ctDNA complexes and it has been explained by an entropy increase, due to the release of the Na + ctDNA counterions and the screened electrostatic interactions [38,56]. An additional way to investigate the charge inversion of nucleic acids caused by their interactions with other species is by using agarose gel electrophoresis. Figure 1c shows that for low enough surfactant concentrations, different for each surfactant, the bands of the surfactant/ctDNA solutions moved towards the anode, indicating that negatively charge nucleic acid was present. For 12PhBr and 12NBr when the charge ratio N/P increases, the migration of the ctDNA through the gel was completely hindered, making evident the charge inversion of the nucleic acid. For DTEABr the charge inversion was observed at high N/P values. No experiments were done for 11PyBr since this surfactant did not cause the charge inversion of ctDNA (see Figure 1b). These results are in agreement with those shown in Figure 1a,b. Pharmaceutics 2021,13, 589 8 of 23 Pharmaceutics 2021, 13, x 8 of 23 Figure 1. (a) Plots of I/Io as function of the charge ratio N/P. Experimental conditions: 10 mM HEPES (pH = 7.4), [EB]=2.4 × 10 −6 M, [ctDNA] = 3.0 × 10 −5 M, and T = 303.0 ± 0.1 K. (b) Plots of the variation of the zeta potential, ζ, with the charge ratio N/P, the experimental values are expressed as the mean ± SD (n = 9). Experimental conditions: [ctDNA] = 3.0 × 10 −5 M, HEPES 10 mM (pH = 7.4) and T = 303.0 ± 0.1 K. (c) Electrophoretic mobility shift assay on an agarose gel (1%) for surfactant/ctDNA complexes. Experiments were run in TAE buffer (40 mM tris-acetate, 1 mM EDTA) and stained with Red Safe. Electrophoresis was performed at 90 V until completion. The insets in Figure 1a,b correspond to the 12NBr surfactant. Figure 1. ( a ) Plots of I/Io as function of the charge ratio N/P. Experimental conditions: 10 mM HEPES (pH = 7.4), [EB]=2.4 × 10 −6 M, [ctDNA] = 3.0 × 10 −5 M, and T = 303.0 ± 0.1 K. ( b ) Plots of the variation of the zeta potential, ζ , with the charge ratio N/P, the experimental values are expressed as the mean ± SD (n= 9). Experimental conditions: [ctDNA] = 3.0 × 10 −5 M, HEPES 10 mM (pH = 7.4) and T = 303.0 ± 0.1 K. ( c ) Electrophoretic mobility shift assay on an agarose gel (1%) for surfactant/ctDNA complexes. Experiments were run in TAE buffer (40 mM tris-acetate, 1 mM EDTA) and stained with Red Safe. Electrophoresis was performed at 90 V until completion. The insets in Figure 1a,b correspond to the 12NBr surfactant. Figure 1indicates that there are strong interactions between ctDNA and 12PhBr and 12NBr. This interaction was weak with DTEABr and, particularly, with 11PyBr. Except Pharmaceutics 2021,13, 589 9 of 23 for the latter, an inversion of the nucleic acid charge was observed, although only a small positive charge was reached for DTEABr. These results point out that, with the exception of 11PyBr, surfactant/ctDNA complexes were formed. One way of studying the DNA conformational changes is by circular dichroism (CD) [ 57 ]. Figure 2shows the CD spectra registered in buffered surfactant/ctDNA solutions (HEPES 10 mM). It was ensured that the presence of the buffer or the surfactants in the solutions did not contribute to the spectra. The CD spectrum of pure DNA in Figure 2 corresponded to that for the right-handed B form of a double stranded nucleic acid at pH 7.4: a negative band close to 247 nm due to the right handed helicity of the polynucleotide, and a positive band at around 280 nm due to the stacking interactions between the base pairs [ 57 ]. For 12PhBr and 12NBr a displacement of the bands to longer wavelengths was observed, together with and a strong decrease in the intensity of the positive band. For 12NBr an increment in the intensity of the negative band was observed for all the N/P values studied, whereas for 12PhBr the negative band intensity remained approximately constant within the N/P range investigated. The formation of highly condensed DNA phases is usually related with these experimental observations [ 40 ]. In the case of the DTEABr solutions, small changes in the spectrum of pure ctDNA were observed, even for high N/P values, indicating that no important conformational changes in the nucleic acid occurred. No changes in the spectrum of pure DNA were observed in the presence of 11PyBr, even at high N/P charge ratio. Therefore, this surfactant did not cause conformational changes in the DNA. Therefore, the CD results seem to indicate that DTEABr and 11PyBr did not compact the polynucleotide, while 12PhBr and 12NBr varied its conformation due to their strong interactions with ctDNA. This hypothesis can be confirmed by visualizing the surfactant/ctDNA complexes through AFM measurements. Figure 3shows the AFM images obtained for 12NBr/ctDNA buffered solutions, and Figure S1 (Supplementary Material) presents the results corresponding to 12PhBr/ctDNA buffered solutions. One can see in Figure 3A the elongated form of pure ctDNA. When the amount of surfactant increased, some globular structures appeared and only globular forms were seen at high charge ratio N/P. Similar images were found for the 12PhBr/ctDNA solutions (Figure S1, Supplementary Material). These results confirm conformational changes of the nucleic acid, and a total condensation in the surfactant/ctDNA complexes formed. Similar results were previously observed for several cationic surfactants/ctDNA systems [11–14,20–22,25,33,34,37,40,42]. Pharmaceutics 2021, 13, x 10 of 23 structures appeared and only globular forms were seen at high charge ratio N/P. Similar images were found for the 12PhBr/ctDNA solutions (Figure S1, Supplementary Material). These results confirm conformational changes of the nucleic acid, and a total condensation in the surfactant/ctDNA complexes formed. Similar results were previously observed for several cationic surfactants/ctDNA systems [11–14,20–22,25,33,34,37,40,42]. Figure 2. Dependence of the circular dichroism spectra of ctDNA (3.0 × 10 −5 M) on the charge ratio N/P. The experimental values are expressed as the mean ± SD (n = 9). Experimental conditions: [ctDNA] = 3.0 × 10 −5 M, HEPES 10 mM (pH = 7.4) and T = 303.0 ± 0.1 K. (a) 12PhBr/ctDNA, (b) 12NBr/ctDNA and (c) DTEAB/ctDNA. Figure 2. Cont. Pharmaceutics 2021,13, 589 16 of 23 Pharmaceutics 2021, 13, x 16 of 23 Figure 7. Dependence of the circular dichroism spectra of pDNA (3.0 × 10 −5 M) in the DOPE/12NBr/pDNA lipoplexes, for various α values, on the ratio L/D. The experimental values are expressed as the mean ± SD (n = 9). Experimental conditions: [pDNA] = 3.0 × 10 −5 M, HEPES 10 mM (pH = 7.4) and T = 303.0 ± 0.1 K. (a) α = 0.2, (b) α = 0.3 and (c) α = 0.7 Figure 8. TEM images, obtained by negative staining, of: (a) liposomes at α = 0.7, and (b) lipoplexes at α = 0.7 and L/D = 8 (Scale bar = 0.5 µm). 3.3. Transfection Efficiency of DOPE/12NBr/pDNA Lipoplexes First, information about the influence of 12NBr concentration on cell viability was obtained using the MTT assay r the human bone osteosarcoma epithelial cells U2OS, which is the cell line used in the transfection experiments. Figure 9 shows the results obtained. The L/D values chosen corresponded to the region where the charge of the lipoplexes was positive, in order to make their crossing through the negatively charged cellular membranes easier. The results show that the cell viability was much higher for α Figure 7. Dependence of the circular dichroism spectra of pDNA (3.0 × 10 −5 M) in the DOPE/12NBr/pDNA lipoplexes, for various α values, on the ratio L/D. The experimental values are expressed as the mean ± SD (n= 9). Experimental conditions: [pDNA] = 3.0 × 10 −5 M, HEPES 10 mM (pH = 7.4) and T = 303.0 ±0.1 K. (a)α= 0.2, (b)α= 0.3 and (c)α= 0.7 The morphology of the liposomes and lipoplexes was investigated using TEM. Two examples of TEM images are shown in Figure 8. The corresponding size distribution histograms are shown in Figure S2 (Supplementary Material). The average size of the lipoplexes with α = 0.7 and L/D = 8 shown in Figure 8b, measured from several TEM images corresponding to different samples, was 160 ± 52 nm, which is agreement, within experimental errors, with that estimated using DLS measurements, shown in Figure 8. For lipoplexes with α = 0.2 and L/D = 20 and α = 0.3 and L/D = 16 the hydrodynamic diameter found by TEM were 178 ± 46 nm and 203 ± 55 nm, respectively, in agreement with those estimated by DLS, within experimental errors. The morphology of both the liposomes and the lipoplexes, was found to be spherical for all the samples investigated. In all cases, Pharmaceutics 2021,13, 589 17 of 23 the chosen L/D values corresponded to cationic lipoplexes, where the nucleic acid was compacted, which are two characteristics required for a potential efficient vector [4,5]. Pharmaceutics 2021, 13, x 16 of 23 Figure 7. Dependence of the circular dichroism spectra of pDNA (3.0 × 10 −5 M) in the DOPE/12NBr/pDNA lipoplexes, for various α values, on the ratio L/D. The experimental values are expressed as the mean ± SD (n = 9). Experimental conditions: [pDNA] = 3.0 × 10 −5 M, HEPES 10 mM (pH = 7.4) and T = 303.0 ± 0.1 K. (a) α = 0.2, (b) α = 0.3 and (c) α = 0.7 Figure 8. TEM images, obtained by negative staining, of: (a) liposomes at α = 0.7, and (b) lipoplexes at α = 0.7 and L/D = 8 (Scale bar = 0.5 µm). 3.3. Transfection Efficiency of DOPE/12NBr/pDNA Lipoplexes First, information about the influence of 12NBr concentration on cell viability was obtained using the MTT assay r the human bone osteosarcoma epithelial cells U2OS, which is the cell line used in the transfection experiments. Figure 9 shows the results obtained. The L/D values chosen corresponded to the region where the charge of the lipoplexes was positive, in order to make their crossing through the negatively charged cellular membranes easier. The results show that the cell viability was much higher for α Figure 8. TEM images, obtained by negative staining, of: ( a ) liposomes at α = 0.7, and ( b ) lipoplexes at α= 0.7 and L/D = 8 (Scale bar = 0.5 µm). 3.3. Transfection Efficiency of DOPE/12NBr/pDNA Lipoplexes First, information about the influence of 12NBr concentration on cell viability was obtained using the MTT assay r the human bone osteosarcoma epithelial cells U2OS, which is the cell line used in the transfection experiments. Figure 9shows the results obtained. The L/D values chosen corresponded to the region where the charge of the lipoplexes was positive, in order to make their crossing through the negatively charged cellular membranes easier. The results show that the cell viability was much higher for α = 0.2 and α = 0.3 than for α = 0.7. On this basis, the transfection experiments were done using lipoplex solutions with αequal to 0.2 and 0.3 at various L/D ratios. Pharmaceutics 2021, 13, x 17 of 23 = 0.2 and α = 0.3 than for α = 0.7. On this basis, the transfection experiments were done using lipoplex solutions with α equal to 0.2 and 0.3 at various L/D ratios. Figure 9. Dependence of the cell viability (%) of the DOPE/12NBr/pDNA lipoplexes on L/D in U2OS cancer cell line, at 48 h, for different cationic surfactant molar fractions α, (a) α = 0.2, (b) α = 0.3 and (c) α = 0.7. The transfection process of the plasmid pEGFP-C1 was carried out on the U2OS cells because this is an easy-to-transfect cell line. Figure 10 presents the percentage of GFP cells with 3 μg pEGFP-C1 in the U2OS cell line. In this Figure, the TE of the transfection reagent FuGENE 6 is also shown for the sake of comparison. The same result can be observed in Figure 11, where representative images of GFP-positive cells after transfection are shown. Expression of GPF is a common readout of transfection which does not require any additional manipulation of the sample, because the GFP is an intrinsically fluorescent protein, so the fluorescence can be readily observed directly. The transfection was carried out for a given α value at the three L/D ratios shown in Figure 9. The TE was negligible for α = 0.2 and L/D equal to 15 and 18. Similar results were found for α = 0.3 and L/D equal to 14 and 16. The amount of pDNA was changed in order to investigate if the concentration of plasmid present in the lipoplexes solutions could influence on the TE observed. No substantial changes were found. A transfection efficiency equal to 1.5% and 2.5% was obtained for the DOPE/12NBr/pDNA lipoplexes with α = 0.2 and L/D = 20 and α = 0.3 and L/D = 12, respectively. The small increase in the TE of the liposomes with α = 0.3, compared to the TE of those with α = 0.2, could be due to the higher cell viability shown by the former with respect to the latter (see Figure 9). The transfection efficiency of the lipoplexes with α = 0.2 and L/D > 20, and α = 0.3 and L/D > 12, could not be carried out because of solubility problems, as mentioned above. In spite of the low TE obtained for the DOPE/12NBr/pDNA lipoplexes investigated, the observation of a positive transfection efficiency compared to the negative control, CNTRL, (see Figure 10), confirmed the possibility of using similar lipoplexes as vectors in gene therapy. Further studies to improve the transfection process through changes in the structure of the cationic surfactant are in progress. In this regard, the variation of the hydrophobic chain length is Figure 9. Dependence of the cell viability (%) of the DOPE/12NBr/pDNA lipoplexes on L/D in U2OS cancer cell line, at 48 h, for different cationic surfactant molar fractions α , ( a ) α = 0.2, (b)α= 0.3 and (c)α= 0.7. The transfection process of the plasmid pEGFP-C1 was carried out on the U2OS cells because this is an easy-to-transfect cell line. Figure 10 presents the percentage of GFP cells with 3 µ g pEGFP-C1 in the U2OS cell line. In this Figure, the TE of the transfection reagent FuGENE 6 is also shown for the sake of comparison. The same result can be Pharmaceutics 2021,13, 589 18 of 23 observed in Figure 11, where representative images of GFP-positive cells after transfection are shown. Expression of GPF is a common readout of transfection which does not require any additional manipulation of the sample, because the GFP is an intrinsically fluorescent protein, so the fluorescence can be readily observed directly. The transfection was carried out for a given α value at the three L/D ratios shown in Figure 9. The TE was negligible for α = 0.2 and L/D equal to 15 and 18. Similar results were found for α = 0.3 and L/D equal to 14 and 16. The amount of pDNA was changed in order to investigate if the concentration of plasmid present in the lipoplexes solutions could influence on the TE observed. No substantial changes were found. A transfection efficiency equal to 1.5% and 2.5% was obtained for the DOPE/12NBr/pDNA lipoplexes with α = 0.2 and L/D = 20 and α = 0.3 and L/D = 12, respectively. The small increase in the TE of the liposomes with α = 0.3, compared to the TE of those with α = 0.2, could be due to the higher cell viability shown by the former with respect to the latter (see Figure 9). The transfection efficiency of the lipoplexes with α = 0.2 and L/D > 20, and α = 0.3 and L/D > 12, could not be carried out because of solubility problems, as mentioned above. In spite of the low TE obtained for the DOPE/12NBr/pDNA lipoplexes investigated, the observation of a positive transfection efficiency compared to the negative control, CNTRL, (see Figure 10), confirmed the possibility of using similar lipoplexes as vectors in gene therapy. Further studies to improve the transfection process through changes in the structure of the cationic surfactant are in progress. In this regard, the variation of the hydrophobic chain length is interesting. Previous results have shown that for a given cationic surfactant there is an optimum tail length for which the TE is maximum [ 76 – 78 ]. This could be related to the formation of a more compact lipid bilayer in the lipoplexes, making the delivery of the genetic material easier. This would result in a less favorable breaking of the lipoplexes as well as in a more difficult escape of the plasmid to the cytosol, thereby making the transfection process more favorable. Pharmaceutics 2021, 13, x 18 of 23 interesting. Previous results have shown that for a given cationic surfactant there is an optimum tail length for which the TE is maximum [76–78]. This could be related to the formation of a more compact lipid bilayer in the lipoplexes, making the delivery of the genetic material easier. This would result in a less favorable breaking of the lipoplexes as well as in a more difficult escape of the plasmid to the cytosol, thereby making the transfection process more favorable. Figure 10. GFP expression of pEGFP-C1 in U2OS cells, using DOPE/NBr/pDNA lipoplexes at α = 0.2 and L/D = 20 and at α = 0.3 and L/D = 12, sorted on the basis of fluorescence at 24 h, posttransfection. CNTRL represents the negative control. FuGENE 6 was used as a positive control. The Figure 10. Cont. Pharmaceutics 2021,13, 589 19 of 23 Pharmaceutics 2021, 13, x 5 of 10 Figure 10. GFP expression of pEGFP-C1 in U2OS cells, using DOPE/NBr/pDNA lipoplexes at α = 0.2 and L/D = 20 and at α = 0.3 and L/D = 12, sorted on the basis of fluorescence at 24 h, posttransfection. CNTRL represents the negative control. FuGENE 6 was used as a positive control. The inset plot shows an enlarged version of the results obtained for α = 0.2 and L/D = 20 and α = 0.3 and L/D = 12. Figure 10. GFP expression of pEGFP-C1 in U2OS cells, using DOPE/NBr/pDNA lipoplexes at α = 0.2 and L/D = 20 and at α = 0.3 and L/D = 12, sorted on the basis of fluorescence at 24 h, post-transfection. CNTRL represents the negative control. FuGENE 6 was used as a positive control. The inset plot shows an enlarged version of the results obtained for α = 0.2 and L/D = 20 and α = 0.3 and L/D = 12. Pharmaceutics 2021, 13, x 19 of 23 inset plot shows an enlarged version of the results obtained for α = 0.2 and L/D = 20 and α = 0.3 and L/D = 12. Figure 11. Representative images of GFP positive cells after transfection with 3 μg of pDNA with DOPE/NBr/pDNA lipoplexes at α = 0.2 and L/D = 20 and at α = 0.3 and L/D = 12. 4. Conclusions In this work the DNA-compacting efficiency of single-chained surfactants with functional groups at the end of the hydrophobic tail was investigated. The results show that, as in the case of single-chained surfactants without these groups, the surfactant tendency of self-aggregation is the main factor determining their capacity to condense the nucleic acid. This is made evident by the linear correlation between ln(K app ) vs. ln(cmc), where K app is the apparent binding equilibrium constant of the surfactants to the DNA. That is, the hydrophobic interactions play a key role in the surfactant/nucleic acid interactions. DOPE/surfactant/pEGFP-C1 lipoplexes of different compositions were prepared using 12NBr, the surfactant with the highest compacting capacity among those studied. The presence of a low surfactant concentration in the lipoplexes was an interesting aspect because it could result in an increase of the cell viability of these nanovehicles in several cell lines. The lipoplexes were prepared by varying the cationic surfactant molar fraction α and changing the mass ratio L/D for each α value. Using several techniques, they were characterized, the results showing the charge inversion of the plasmid pEGFP-C1 and its subsequent compaction when L/D increased, for a given α value. The charge inversion was observed at lower L/D ratios the higher the α value is. This compaction was a prerequisite for gene transfection. Cytotoxicity studies showed that for α values equal to 0.2 and 0.3, changing the L/D ratio, the cell viability for human bone osteosarcoma epithelial cells U2OS was close to 60%. The transfection process of the plasmid pEGFP-C1 was carried out on U2OS cells using lipoplexes at different cationic surfactant molar fractions α, varying the L/D mass ratio. Only for DOPE/12NBr/ pEGFP-C1 lipoplexes with α = 0.2 and L/D = 20 and α = 0.3 and L/D = 12 was transfection observed, the TE being equal to 1.5% and 2.5%, respectively. Figure 11. Representative images of GFP positive cells after transfection with 3 µ g of pDNA with DOPE/NBr/pDNA lipoplexes at α= 0.2 and L/D = 20 and at α= 0.3 and L/D = 12. 4. Conclusions In this work the DNA-compacting efficiency of single-chained surfactants with functional groups at the end of the hydrophobic tail was investigated. The results show that, as in the case of single-chained surfactants without these groups, the surfactant tendency of self-aggregation is the main factor determining their capacity to condense the nucleic acid. This is made evident by the linear correlation between ln(K app ) vs. ln(cmc), where K app is the apparent binding equilibrium constant of the surfactants to the DNA. That is, the hydrophobic interactions play a key role in the surfactant/nucleic acid interactions. DOPE/surfactant/pEGFP-C1 lipoplexes of different compositions were prepared using 12NBr, the surfactant with the highest compacting capacity among those studied. Pharmaceutics 2021,13, 589 20 of 23 The presence of a low surfactant concentration in the lipoplexes was an interesting aspect because it could result in an increase of the cell viability of these nanovehicles in several cell lines. The lipoplexes were prepared by varying the cationic surfactant molar fraction α and changing the mass ratio L/D for each α value. Using several techniques, they were characterized, the results showing the charge inversion of the plasmid pEGFP-C1 and its subsequent compaction when L/D increased, for a given α value. The charge inversion was observed at lower L/D ratios the higher the α value is. This compaction was a prerequisite for gene transfection. Cytotoxicity studies showed that for α values equal to 0.2 and 0.3, changing the L/D ratio, the cell viability for human bone osteosarcoma epithelial cells U2OS was close to 60%. The transfection process of the plasmid pEGFP-C1 was carried out on U2OS cells using lipoplexes at different cationic surfactant molar fractions α , varying the L/D mass ratio. Only for DOPE/12NBr/ pEGFP-C1 lipoplexes with α = 0.2 and L/D = 20 and α = 0.3 and L/D = 12 was transfection observed, the TE being equal to 1.5% and 2.5%, respectively. These TE values are low, but they point out that similar lipoplexes could be more efficient vectors. Changes in the structure of the surfactant will be necessary to improve the TE. One of the strategies to follow is to vary the length of the hydrophobic chain because, for a given cationic surfactant, there is an optimum tail length for which the TE is maximal [76–78]. Supplementary Materials: The following are available online at https://www.mdpi.com/article/10 .3390/pharmaceutics13040589/s1, Figure S1: AFM topographic images of 12PhBr/ctDNA buffered solutions, in 10 mM HEPES (pH = 7.4), adsorbed on APTES modified mica surface. [ctDNA] = 0.6 µM . (A) N/P = 9; (B) N/P = 25. Figure S2: Histograms generated using the size distribution tool of the ImageJ bundled with 64-bit Java 1.8.0_172 software of the TEM microscope for: (A) liposomes at α= 0.7 , and (B) lipoplexes at α = 0.7 and L/D = 8. Table S1: Values of the critical micellar concentration of the surfactants investigated in this work. Author Contributions: Conceptualization, M.L.-L., P.L.-C. and M.L.M.; methodology, F.J.O., J.A.L., E.G.-D., M.L.-L., P.H., M.G.-C., P.L.-C. and M.L.M.; software, J.A.L., F.J.O. and P.H.; validation, M.L.-L., P.L.-C., P.H. and M.L.M.; formal analysis, F.J.O., J.A.L., M.L.-L., P.L.-C. and M.L.M.; investigation, F.J.O., J.A.L., E.G.-D., M.L.-L., P.L.-C., P.H., M.G.-C. and M.L.M.; resources, P.L.-C., P.H. and M.L.M.; data curation, F.J.O., J.A.L., E.G.-D., M.G.-C. and M.L.M.; writing—original draft preparation, F.J.O., M.L.-L., P.L.-C., P.H. and M.L.M.; writing—review and editing, F.J.O., M.L.-L., P.L.-C., P.H. and M.L.M.; visualization, F.J.O., M.L.-L., P.L.-C., P.H. and M.L.M.; supervision, F.J.O., M.L.-L., P.L.-C. and M.L.M.; project administration, M.L.-L., P.L.-C. and M.L.M.; funding acquisition, P.L.-C., P.H. and M.L.M. All authors have read and agreed to the published version of the manuscript. Funding: This work was financed by the Consejería de Educación y Ciencia de la Junta de Andalucía (FQM-206 and FQM-274, and PI-0005-2018), the VI Plan Propio Universidad de Sevilla (PP2019/00000748), and the European Union (Feder Funds). Institutional Review Board Statement: Not applicable. Informed Consent Statement: Not applicable. Conflicts of Interest: The authors declare no conflict of interest. References 1. Kirby, A.J.; Camilleri, P.; Engberts, J.B.F.N.; Feiters, C.; Nolte, R.J.M.; Söderman, O.; Bergsma, M.; Bell, P.C.; Fielden, M.L.; García Rodríguez, C.L.; et al. Gemini surfactants: New synthetic vectors for gene transfection. Angew. Chem. Int. Ed. 2003 ,42, 1448–1457. [CrossRef] [PubMed] 2. Mintzer, M.A.; Simanek, E.E. Nonviral vectors for gene delivery. Chem. Rev. 2009,109, 259–302. [CrossRef] [PubMed] 3. Zuhorn, I.; Engberts, J.B.F.N.; Hoekstra, C. Gene delivery by cationic lipid vectors: Overcoming cellular barriers. Eur. Biophys. J. 2007,36, 349–362. [CrossRef] [PubMed] 4. Ahmed, T.; Kamel, A.O.; Wettig, S.D. Interactions between DNA and gemini surfactant: Impact on gene therapy: Part I. Nanomedicine 2016,11, 289–306. [CrossRef] 5. Ahmed, T.; Kamel, A.O.; Wettig, S.D. Interactions between DNA and gemini surfactant: Impact on gene therapy: Part II. Nanomedicine 2016,11, 403–420. [CrossRef] 6. Kim, K.; Chen, W.C.W.; Heo, Y.; Wang, Y. Polycations and their biomedical applications. Progr. Polym. Sci. 2016,60, 18–50. [CrossRef] Pharmaceutics 2021,13, 589 21 of 23 7. Zhi, D.; Bai, Y.; Yang, J.; Cui, S.; Zhao, Y.; Chen, H.; Zhang, S. A review on cationic lipids with different linkers for gene delivery. Adv. Colloid Interface Sci. 2018,253, 117–140. [CrossRef] 8. Kumar, V.; Palazzolo, S.; Bayda, S.; Corona, G.; Toffoli, G.; Rizzolio, F. DNA nanotechnology for cancer therapy. Theranostics 2016 , 6, 710–725. [CrossRef] [PubMed] 9. Chaudhuri, T.; Pan, A.; Das, S.; Moulik, S.P. Ratiometric interactions of Anionic Surfactants with Calf Thymus DNA Bound cationic surfactants: Study II. J. Surfactants Deterg. 2018,21, 127–137. [CrossRef] 10. Ren, W.; Liu, H.; Yang, W.; Fan, Y.; Yang, L.; Wang, Y.; Liu, C.; Li, Z. A cytometric bead assay for sensitive DNA detection based on-enzyme-free signal amplification of hybridization chain reaction. Biosens. Bioelectron. 2013 ,49, 380–386. [CrossRef] [PubMed] 11. Lopez-López, M.; López-Cornejo, P.; Martín, V.I.; Ostos, F.J.; Checa-Rodríguez, C.; Prados-Carvajal, R.; Lebron, J.A.; Huertas, P.; Moya, M.L. Importance of hydrophobic interactions in the single-chained cationic surfactant-DNA complexation. J. Colloid Interface Sci. 2018,521, 197–205. [CrossRef] 12. Li, X.; Sun, D.; Chen, Y.; Wang, K.; He, Q.; Wang, G. Studying compaction-decompaction of DNA molecules induced by surfactants. Biochem. Biophys. Res. Commun. 2018,495, 2559–2565. [CrossRef] [PubMed] 13. Fan, Y.; Wang, H.; He, C.; Qiao, F.; Wang, S.; Wang, Y. DNA Condensation Induced by a Star-Shaped Hexameric Cationic Surfactant. ACS Appl. Mater. Interfaces 2017,9, 23333–23341. [CrossRef] [PubMed] 14. Bustamante, C.; Bryant, Z.; Smith, S.B. Ten years of tension: Single-molecule DNA mechanics. Nature 2003 ,421, 423–427. [CrossRef] [PubMed] 15. Ritort, F.; Mihardja, S.; Smith, S.B.; Bustamante, C. Condensation transition in DNA-polyaminoamide dendrimer fibers studied using optical tweezers. Phys. Rev. Lett. 2006,96, 118301. [CrossRef] 16. Husale, S.; Grange, W.; Karle, M.; Bürgi, S.; Hegner, M. Interaction of cationic surfactants with DNA: A single-molecule study. Nucleic Acids Res. 2008,36, 1443–1449. [CrossRef] [PubMed] 17. Feng, L.; Xu, L.; Dong, S.; Hao, J. Thermo-reversible capture and release of DNA by zwitterionic surfactants. Soft Matter 2016 ,12, 7495–7504. [CrossRef] 18. Hao, B.; Wang, K.; Zhou, Y.; Sui, C.; Wang, L.; Bai, R.; Yang, Z. Label-free detecting of the compaction and decompaction of ctDNA molecules induced by surfactants with SERS based on a nanoPAA-ZnCl 2 -AuLs solid substrate. ACS Omega 2020 ,5, 1109–1119. [CrossRef] 19. Zhi, D.; Zhang, S.; Cui, S.; Zhao, Y.; Wang, Y.; Zhao, D. The head group evolution of cationic lipids for gene delivery. Bioconj. Chem. 2013,24, 487–519. [CrossRef] 20. Martín, V.I.; Sarrión, B.; López-López, M.; López-Cornejo, P.; Robina, I.; Moyá, M.L. Reversibility of the interactions between a novel surfactant derived from lysine and biomolecules. Colloids Surf. B 2015,135, 346–356. [CrossRef] [PubMed] 21. Zinchenko, A.; Pyshkina, O.; Lezov, A.; Sergeyev, O.; Yoshikawa, K. Single DNA Molecules: Compaction and Decompaction. In DNA Interactions with Polymers and Surfactants; Dias, R.S., Lindman, B., Eds.; Wiley: Hoboken, NJ, USA, 2008; pp. 59–88. [CrossRef] 22. Cai, K.; Cheng, R.; Wang, C.; Xia, Y.; Xu, T.; Gan, C. Interactions with ctDNA of novel sugar-based gemini cationic surfactants. Int. J. Biol. Macro. 2020,156, 805–811. [CrossRef] 23. Zakharova, L.A.; Kaupova, G.I.; Gabdrakhmanov, D.R.; Gaynanova, G.A.; Ermakova, E.A.; Mukhitov, A.R.; Galkina, I.V.; Cheresiz, S.V.; Pokrovsky, A.G.; Skvortsova, P.V.; et al. Alkyl triphenylphosphonium surfactants as nucleic acid carriers: Complexation efficacy toward DNA decamers, interaction with lipid bilayers and cytotoxicity studie. Phys. Chem. Chem. Phys. 2019 ,21, 16706–16717. [CrossRef] [PubMed] 24. Piecuch, A.; Lamch, L.; Paluch, E.; Obłazk, E.; Wilk, K.A. Biofilm prevention by dicephalic cationic surfactants and their interactions with DNA. J. Appl. Microbiol. 2016,121, 682–692. [CrossRef] 25. Lebrón, J.A.; Ostos, F.J.; López-López, M.; Moyá, M.L.; Kardell, O.; Sánchez, A.; Carrasco, C.J.; García-Calderón, M.; GarcíaCalderón, C.B.; Rosado, I.V.; et al. Preparation and characterization of metallomicelles of Ru(II): Cytotoxic activity and use as vectors. Colloid Surf. B 2019,175, 116–125. [CrossRef] [PubMed] 26. Bhar, R.; Kaur, G.; Mehta, S.K. Exploring interactions of copper hybrid surfactants with calf thymus-DNA. J. Mol. Liq. 2017 ,241, 715–721. [CrossRef] 27. Zhang, L.; Dong, Y.; Zhang, Z.; Guo, X. Micellization of lactosylammonium surfactants with different counter ions and their interaction with DNA. J. Chem. Eng. Data 2016,61, 2969–2978. [CrossRef] 28. Fisicaro, E.; Compari, E.; Bacciottini, F.; Contardi, L.; Pongiluppi, E.; Barbero, N.; Viscardi, G.; Quagliotto, P.; Donofrio, G.; Krafft, M.P. Nonviral gene-delivery by highly fluorinated gemini bispyridinium surfactant-based DNA nanoparticles. J. Colloid Interface Sci. 2017,487, 182–191. [CrossRef] [PubMed] 29. Wang, L.; Dong, S.; Hao, J. Recent progress of magnetic surfactants: Self-assembly, properties and functions. Curr. Opin. Colloid Interface Sci. 2018,35, 81–90. [CrossRef] 30. Guo, L.; Zhang, Z.; Qiao, H.; Liu, M.; Shen, M.; Yuan, T.; Chen, J.; Dionysiou, D.D. Spectroscopic study on interaction between three cationic surfactants with different alkyl chain lengths and DNA. Spectrochim. Acta A 2015,151, 237–246. [CrossRef] 31. Pietralik, Z.; Kumita, J.R.; Dobson, C.M.; Kozak, M. The influence of novel gemini surfactants containing cycloalkylside-chains on the structural phases of DNA in solution. Colloid Surf. B 2015,131, 83–92. [CrossRef] [PubMed] 32. Aicart, E.; Junquera, E. Recent progress in gene therapy to deliver nucleic acids with multivalent cationic vectors. Adv. Colloid Interface Sci. 2016,233, 161–175. [CrossRef] Pharmaceutics 2021,13, 589 22 of 23 33. Kumar, K.; Barrán-Berdón, L.A.; Datta, S.; Múñoz-Úbeda, M.; Aicart-Ramos, C.; Kondaiah, P.; Junquera, E.; Aicart, E. A delocalizable cationic headgroup together with an oligooxyethylene spacer in gemini cationic lipids improves their biological activity as vectors of plasmid DNA. J. Mater. Chem. 2015,2, 1495–1506. [CrossRef] [PubMed] 34. Grueso, E.; Roldan, E.; Perez-Tejeda, P.; Kuliszewska, E.; Molero, B.; Brecker, L.; Giraldez-Perez, R.M. Reversible DNA compaction induced by partial intercalation of 16-Ph-16 gemini surfactants: Evidence of triple helix formation. Phys. Chem. Chem. Phys. 2018 , 20, 24902–24914. [CrossRef] [PubMed] 35. Barbero, N.; Magistris, C.; Quagliotto, P.; Bonandini, L.; Barolo, C.; Buscaino, R.; Compari, C.; Contardi, L.; Fisicaro, E.; Viscardi, G. Synthesis, physicochemical characterization, and interaction with DNA of long-alkyl-chain gemini pyridinium surfactants. ChemPlusChem 2015,80, 952–962. [CrossRef] [PubMed] 36. Wettig, S.D.; Verrall, R.D.; Foldvari, M. Gemini surfactants: A new family of building blocks for non-viral gene delivery systems. Curr. Gene Ther. 2008,8, 9–23. [CrossRef] 37. Sarrión, B.; Bernal, E.; Martín, V.I.; López-López, M.; López-Cornejo, P.; García-Calderón, M.; Moyá, M.L. Binding of 12-s12 dimeric surfactants to calf thymus DNA: Evaluation of the spacer length influence. Colloid Surf. B 2016 ,144, 311–318. [CrossRef] [PubMed] 38. Karlsson, L.; van Eijk, M.C.P.; Söderman, P. Compaction of DNA by gemini surfactants: Effects of surfactant architecture. J. Colloid Interface Sci. 2002,252, 290–296. [CrossRef] [PubMed] 39. Silva, S.G.; Oliveira, I.S.; do Vale, M.L.C.; Marques, E.F. Serine-based gemini surfactants with different spacer linkages: From self-assembly to DNA compaction. Soft Matter 2014,46, 9352–9361. [CrossRef] 40. Bombelli, C.; Borocci, S.; Diociaiuti, M.; Galantini, L.; Luciani, P.; Mancini, G.; Sacco, M.G. Role of the spacer of cationic gemini amphiphiles in the condensation of DNA. Langmuir 2005,21, 10271–10274. [CrossRef] [PubMed] 41. Hubˇcík, L.; Galliková, D.; Pullmannová, P.; Lacinová, L.; Sulová, Z.; Hanulová, M.; Funari, S.S.; Devínsky, F.; Uhríková, D. DNA-DOPE-gemini surfactants complexes at low surface charge density: From structure to transfection efficiency. Gen. Physiol. Biophys. 2018,37, 57–69. [CrossRef] [PubMed] 42. López, A.; López-Cornejo, P.; López-López, M.; Lebrón, J.A.; Ostos, F.J.; Pérez-Alfonso, D.; Oviedo, J.; Laschewsky, A.; Moyá, M.L. Influence of the degree of oligomerization of surfactants on the DNA/surfactant interaction. Colloids Surf. B 2019 ,182, 110399. [CrossRef] [PubMed] 43. Asayama, S.; Nohara, A.; Negishi, Y.; Hawakami, H. Alkylimidazolium end-modified poly(ethylene glycol) to form the mono-ion complex with plasmid DNA for in vivo gene delivery. Biomacromolecules 2014,15, 997–1001. [CrossRef] [PubMed] 44. Liu, Y.J.; Chao, H.; Tan, L.F.; Yuan, L.X.; Ji, L.N. Ruthenium(II) mixed-ligand complexes containing 2-(6-methyl-3-chromonyl)- imidazol[4,5-f][1,10]-phenanthroline: Synthesis, DNA-binding and photoclavage studies. Inorg. Chim. Acta 2006 ,359, 3807–3814. [CrossRef] 45. Secco, F.; Venturini, M.; Biver, T.; Sanchez, T.; Prado-Gotor, R.; Grueso, E. Solvent effects on the kinetics of the interaction of 1-pyrenecarboxaldehyde with calf thymus DNA. J. Phys. Chem. B 2010,114, 4686–4691. [CrossRef] [PubMed] 46. Ostos, F.J. Use of Calixarene-Derived Macrocyclic Compounds as Drug Nanocarriers. Ph.D. Thesis, University of Seville, Sevilla, Spain, 2020. 47. Martín, M.V.; Ostos, F.J.; Ángulo, M.; Márquez, A.; López-Cornejo, P.; López-López, M.; Carmona, M.T.; Moyá, M.L. Host-guest interactions between cyclodextrins and surfactants with functional groups at the end of the hydrophobic tail. J. Colloid Interface Sci. 2017,491, 336–348. [CrossRef] [PubMed] 48. Martín, V.I.; Angulo, M.; López-Cornejo, P.; López-López, M.; Marchena, M.J.; Moyá, M.L. Stoppering/unstoppering of a rotaxane formed between an N-hetorycle ligand containing surfactant: β -cyclodextrin pseudorotaxane and pentacyanoferrate(II) ions. J. Colloid Interface Sci. 2017,497, 343–349. [CrossRef] [PubMed] 49. Zhang, H. Thin-Film hydration followed by extrusion method for liposome preparation. Methods Mol. Biol. 2017 ,1522, 17–22. [CrossRef] [PubMed] 50. Moyá, M.L.; López-López, M.; Lebrón, J.A.; Ostos, F.J.; Pérez, D.; Camacho, V.; Beck, V.; Merino-Bohórquez, V.; Camean, M.; Madinabeitia, N.; et al. Preparation and characterization of new liposomes. Bactericidal activity of cefepime encapsulated into cationic liposomes. Pharmaceutics 2019,11, 69. [CrossRef] [PubMed] 51. Meerloo, J.; Kaspers, G.J.L.; Cloos, J. Cell Sensitivity Assays: The MTT Assay. Methods Mol. Biol. 2011,731, 237–245. [CrossRef] 52. Cosa, G.; Focsaneau, K.S.; Mc Lean, J.R.N.; Mac Namee, J.P.; Scaiano, J.C. Photophysical properties of fluorescent DNA-dyes bound to singleand double-stranded DNA in aqueous buffered solutions. Photochem. Photobiol. 2001,73, 585–599. [CrossRef] 53. Adjimatera, N.; Neal, A.P.; Blagbrough, I.S. Fluorescence techniques in non-viral gene therapy. In Fluorescence Spectroscopy in Biology Advanced Methods and Their Applications to Membranes, Proteins, DNA, and Cells; Hof, M., Hutterer, R., Fidler, V., Eds.; Springer: Berlin, Germany, 2005; Volume 3, pp. 201–228. [CrossRef] 54. Geall, A.J.; Blagbrough, I.S. Rapid and sensitive ethidium bromide fluorescence quenching assay of polyamine conjugate-DNA interactions for the analysis of lipoplex formation in gene therapy. J. Pharm. Biomed. Anal. 2000,22, 849–859. [CrossRef] 55. Múñoz-Úbeda, M.; Misra, S.K.; Barrán-Berdón, A.L.; Aicart-Ramos, C.; Sierra, M.B.; Biswas, J.; Kondaiah, P.; Junquera, E.; Bhattacharya, S.; Aicart, E. Why is less cationic lipid required to prepare lipoplexes from plasmid DNA than linear DNA in gene therapy? J. Am. Chem. Soc. 2011,133, 18014–18017. [CrossRef] 56. Shklovskii, B.I. Screening of a micro Akon by multitalented ion: Correlation-induced inversion charge. Phys. Rev. E 1999 ,60, 5802–5811. [CrossRef] [PubMed] Pharmaceutics 2021,13, 589 23 of 23 57. Neidle, S. Nucleic Acid Structure and Recognition; Oxford University Press: New York, NY, USA, 2002; pp. 89–138. 58. Veeralakshmi, S.; Neru, S.; Sabapathi, G.; Arunachalam, S.; Venuvanaligam, P.; Kumar, P.; Anusha, C.; Ravikumar, V. Single and double chain surfactant-cobalt (III) complexes: The impact of hydrophobicity on the interaction with calf thymus DNA, and their biological activities. RSC Adv. 2015,5, 31746–31758. [CrossRef] 59. Camesano, A.; Nagarajan, R. Micelle formation and cmc of gemini surfactants: A thermodynamic model. Colloids Surf. A 2000 , 167, 165–177. [CrossRef] 60. Shim, G.; Kim, D.; Le, Q.-V.; Park, G.T.; Kwon, T.; Oh, Y.-K. Nonviral delivery systems for cancer gene therapy: Strategies and challenges. Curr. Gene Ther. 2018,18, 3–20. [CrossRef] [PubMed] 61. Hidai, C.; Kitano, H. Nonviral gene therapy for cancer: A Review. Diseases 2018,6, 57. [CrossRef] 62. Huang, Z.; Tomitaka, A.; Raymond, A.; Nair, M. Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS. Gene Ther. 2017,24, 377–384. [CrossRef] [PubMed] 63. Wei, Y.; Sticca, R.P.; Holmes, L.M.; Burgin, K.E.; Li, J.; Williamson, J.; Evans, L.; Smith, S.J.; Stephenson, J.J.; Wagner, T.E. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses. Int. J. Oncol. 2006,28, 585–593. [CrossRef] [PubMed] 64. Blagbrough, I.S.; Metwally, A.A. siRNA and Gene Formulation for Efficient Gene Therapy. In Gene Therapy—Tools and Potential Applications; Martin Molina, F., Ed.; InTechOpen: Rijeka, Croatia, 2013; pp. 135–173. [CrossRef] 65. Blagbrough, I.S.; Metwally, A.A.; Ahmed, O.A.A. Polyamine-based agents for gene and siRNA transfer. In Polyamine Drug Discovery; Woster, P.M., Casero, R.A., Jr., Eds.; RSC: Cambridge, UK, 2012; pp. 205–237. [CrossRef] 66. Ghonaim, H.M.; Ahmed, O.A.A.; Pourzand, C.; Blagbrough, I.S. Varying the chain length in N 4 ,N 9 -diacyl spermines: Non-viral lipopolyamine vectors for efficient plasmid DNA formulation. Mol. Pharm. 2008,5, 1111–1121. [CrossRef] 67. Metwally, A.A.; Pourzand, C.; Blagbrough, I.S. Efficient gene silencing by self-assembled complexes of siRNA and symmetrical fatty acid amides of spermine. Pharmaceutics 2011,3, 125–140. [CrossRef] 68. Gallego-Yerga, L.; Blanco-Fernández, L.; Martínez-Negro, M.; Vélaz, I.; Aicart, E.; Junquera, E.; Mellet, M.D.C.O.; De Ilarduya, C.T.; Fernández, J.M.M.G.; Benito, J.M. Plasmid-Templated Control of DNA Cyclodextrin nanoparticles morphology through Molecular Vector Design for Effective Gene Delivery. Chem. A Eur. J. 2018,24, 3825–3835. [CrossRef] 69. Blanco, J.L.J.; Benito, J.M.; Mellet, C.O.; García-Fernández, J.M. Molecular nanoparticle-based gene delivery systems. J. Drug Deliv. Sci. Technol. 2017,42, 18–37. [CrossRef] 70. Ostos, F.J.; Lebrón, J.A.; Moyá, M.L.; López-López, M.; Sánchez, A.; Clavero, A.; García-Calderón, C.B.; Rosado, I.; Cornejo, P.L. P-Sulfocalix[6]arene as nanocarrier for controlled delivery of doxorubicin. Chem. Asian J. 2017 ,12, 679–689. [CrossRef] [PubMed] 71. Wang, A.Z.; Lin, W.; Liu, D.; He, C. Application of liposomal technologies for delivery of platinum analogs in oncology. Int. J. Nanomed. 2013,8, 3309–3319. [CrossRef] [PubMed] 72. Barron, L.G.; Uyechi, L.S.; Szoka, F.C.; Szoka, F.C., Jr. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes. Gene Ther. 1999,6, 1179–1183. [CrossRef] 73. Semple, S.C.; Klimuk, S.K.; Harasym, T.O.; Hope, M.J. Lipid-based formulations of antisense oligonucleotides for systemic delivery applications. Method. Enzym. 2000,313, 322–341. [CrossRef] 74. Srinivas, R.; Samanta, S.; Chaudhuri, A. Cationic amphiphiles: Promising carriers of genetic materials in gene therapy. Chem. Soc. Rev. 2009,38, 3326–3338. [CrossRef] [PubMed] 75. Mignet, N.; Vandermeulen, G.; Pembouong, G.; Largeau, C.; Thompson, B.; Spanedda, M.V.; Wasungu, L.; Rols, M.-P.; Bessodes, M.; Bureau, M.F.; et al. Cationic and anionic lipoplexes inhibit gene transfection by electroporation in vivo .J. Gene Med. 2010 ,12, 491–500. [CrossRef] [PubMed] 76. Andrzejewska, W.; Wilkowska, P.; Cheabaszczewska, M.; Kozak, M. The study of complexation between dicationic surfactants and the DNA duplex using structural and spectroscopic methods. RSC Adv. 2017,7, 26006–26018. [CrossRef] 77. Xu, Y.; Szoka, F. Mechanism of DNA release from cationic liposomes/DNA complexes used in cell transfection. Biochemistry 1996 , 35, 5616–5623. [CrossRef] [PubMed] 78. Duangjit, S.; Pamornpathomkul, B.; Opanasopit, P.; Rojanarata, T.; Obata, Y.; Takayama, K.; Ngawhirunpat, T. Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes. Int. J. Nanomed. 2014 ,9, 2005–2017. [CrossRef] [PubMed]